| Patents for A61P 21 - Drugs for disorders of the muscular or neuromuscular system (23,287) |
|---|
| 07/28/2011 | US20110183019 Methods of screening for and treating autism spectrum disorders and compositions for same |
| 07/28/2011 | US20110182913 Anti fgf23 antibody and a pharmaceutical composition comprising the same |
| 07/28/2011 | CA2787248A1 Piperazine compound having a pgds inhibitory effect |
| 07/27/2011 | EP2347760A2 Use of follistatin for the manufacture of a medicament for the treatment of a non-degenerative nervous system disorder |
| 07/27/2011 | EP2346905A1 Methods and compositions for treatment of myotonic dystrophy |
| 07/27/2011 | EP1443928B1 Treatment of neurodegenerative diseases and cancer of the brain |
| 07/27/2011 | CN102133264A Paste for relieving rigidity of muscles and promoting blood circulation |
| 07/26/2011 | US7985887 Regulation of endogenous gene expression in cells using zinc finger proteins |
| 07/26/2011 | US7985411 Activatable recombinant neurotoxins |
| 07/26/2011 | CA2484482C Triple monoamine reuptake inhibitors for the treatment of chronic pain |
| 07/21/2011 | US20110178180 Deuterium-enriched colchicine, thiocolchicine, and derivatives thereof; methods of preparation; and use thereof |
| 07/21/2011 | US20110178178 Treatment of Motor Fluctuations |
| 07/21/2011 | US20110178165 Tetrahydrofuranyl sulfonamides and pharmaceutical compositions thereof |
| 07/21/2011 | US20110178121 Methods for Treating Pain |
| 07/21/2011 | US20110178096 Octahydropentalene compounds as chemokine receptor antagonists |
| 07/21/2011 | US20110178023 Use Of SCO-Spondin Peptides For Inhibiting Or Preventing Neuronal Apoptosis Mediated By Cell Death Receptor Ligands |
| 07/21/2011 | US20110177595 Multipotent Adult Stem Cells, Sources Thereof, Methods of Obtaining and Maintaining Same, Methods of Differentiation Thereof, Methods of Use Thereof and Cells Derived Thereof |
| 07/21/2011 | US20110177152 Drug/Drug Delivery Systems For The Prevention And Treatment Of Vascular Disease |
| 07/21/2011 | US20110177150 Implantable tissue compositions and method |
| 07/21/2011 | US20110177001 Screening assay employing dex and gdf8 |
| 07/20/2011 | EP2345412A1 Use of high-dose oxazaphosphorine drugs for treating immune disorders |
| 07/20/2011 | EP1833847B1 Igf-1 fusion polypeptides and therapeutic uses thereof |
| 07/20/2011 | EP1569668B1 An organic extract of geum japonicum thumb variant and use thereof |
| 07/20/2011 | EP1496930B1 G-type peptides to ameliorate atherosclerosis |
| 07/20/2011 | EP1181317B1 An integrin heterodimer and an alpha subunit thereof |
| 07/20/2011 | CN102131803A Solid forms of (1r,2s,3r)-1-(2-(isoxazol-3-yl)-1h-imidazol-4-yl)butane-1,2,3,4-tetraol and methods of their use |
| 07/20/2011 | CN102125612A Chinese medicinal preparation for treating acute lumbar sprain |
| 07/20/2011 | CN102125594A Method for determining content of active compounds in Chinese medicinal freeze-dried injection |
| 07/20/2011 | CN101312965B Morpholine type cinnamide compound |
| 07/19/2011 | US7982067 Phenethanolamine derivatives for treatment of respiratory diseases |
| 07/19/2011 | US7982037 (5-Methyl-2H-pyrazol-3-yl)-(2-phenylsulfanyl-quinazolin-4-yl)-amine; Anticancer agents; antidiabetic agents; Alzheimer's disease; inhibitors of Aurora-2 and GSK-3 |
| 07/19/2011 | US7981894 Polymorphic forms of 1-′4-(5-cyanoindol-3-yl) butyl-4-(2-carbamoylbenzofuran-5-yl)piperazine hydrochloride |
| 07/19/2011 | US7981676 Method for transfer of molecular substances with prokaryotic nucleic acid-binding proteins |
| 07/19/2011 | US7981448 Method of treating necrotizing enterocolitis in a patient, which includes administering a pharmaceutical composition that includes carbon monoxide to the patient. |
| 07/19/2011 | US7981413 Using cell surface adhesion proteins specific immunoglobulin to target therapeutics to tumorous; immunodiagnostics; immunotherapy |
| 07/19/2011 | CA2472713C N-(benzyl)aminoalkylcarboxylates, phosphinates, phosphonates and tetrazoles as edg receptor agonists |
| 07/19/2011 | CA2432464C Excitatory amino acid receptor antagonists |
| 07/19/2011 | CA2380920C Use of chemical chelators as reversal agents for drug-induced neuromuscular block |
| 07/14/2011 | US20110172306 Creatine ester pronutrient compounds and formulations |
| 07/14/2011 | US20110172301 Use of anti-oxidant compounds for muscle recovery |
| 07/14/2011 | US20110172280 Substituted Benzimidazoles |
| 07/14/2011 | US20110172231 2,4- diaminopyrimidine derivatives |
| 07/14/2011 | US20110172159 Proteic acid polymer, production processes, use of proteic acid polymer, pharmaceutical composition and method of treatment |
| 07/14/2011 | US20110171332 Leucojum bulb extracts and use thereof |
| 07/14/2011 | US20110171226 Novel Subtype of Closteridium Botulinum Neurotoxin Type A and Uses Thereof |
| 07/13/2011 | EP2343316A1 Ligand binding site of RAGE and uses thereof |
| 07/13/2011 | EP1509489B1 Amines that inhibit a mammalian anandamide transporter, and methods of use thereof |
| 07/13/2011 | EP1289553B1 Nrg-2 nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods |
| 07/13/2011 | CN102124009A Kinase inhibitors and methods of use |
| 07/13/2011 | CN102123735A Agent for induction/maintenance of remission |
| 07/13/2011 | CN102119970A Chinese medicinal composition for treating myasthenia gravis |
| 07/13/2011 | CN101293043B Pharmaceutical formulation for treating muscular atrophy lateral sclerosis and preparing method |
| 07/12/2011 | US7976836 Treatment of stroke using placental stem cells |
| 07/12/2011 | CA2481767C Severe sepsis preventive therapeutic agent |
| 07/12/2011 | CA2458455C Pharmaceutical compositions comprising colloidal silicon dioxide |
| 07/12/2011 | CA2392046C Biglycan and uses thereof in stabilizing dystrophin associated protein complexes |
| 07/12/2011 | CA2389685C Novel heterocyclic compounds and their use as medicaments |
| 07/12/2011 | CA2341336C Elongase genes and uses thereof |
| 07/12/2011 | CA2302874C Jnk3 modulators and methods of use |
| 07/12/2011 | CA2162262C Methods for treating muscle diseases and disorders |
| 07/07/2011 | WO2011081173A1 Tetracyclic compound |
| 07/07/2011 | US20110166169 Novel hsp90 inhibitory carbazole derivatives, compositions containing same and use thereof |
| 07/07/2011 | US20110166104 Boron-containing small molecules |
| 07/07/2011 | US20110166093 Use of adenosine receptor agonists in therapy |
| 07/07/2011 | US20110166082 Antisense composition and method for treating muscle atrophy |
| 07/07/2011 | US20110166081 Alpha-dystroglycan as a Protein Therapeutic |
| 07/07/2011 | US20110165098 Methods to prevent cytotoxicity using n-acetyl-cysteine |
| 07/07/2011 | US20110165063 Il-1 binding proteins |
| 07/06/2011 | EP2341080A1 Humanized immunoglobulins and their production and use |
| 07/06/2011 | EP2341068A1 A method of detecting and/or identifying adeno-associated virus (AAV) sequences and isolating novel sequences identified thereby |
| 07/06/2011 | EP1228076B1 A substantially cell membrane impermeable compound and use thereof |
| 07/06/2011 | CN101837080B Topical ointment externally used for treating cervical spondylosis |
| 07/05/2011 | US7973015 Induction of exon skipping in eukaryotic cells |
| 07/05/2011 | CA2476583C Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase |
| 06/30/2011 | WO2011078360A1 Amide compound |
| 06/30/2011 | WO2011078221A1 Imidazopyridazine compounds |
| 06/30/2011 | WO2011077252A2 Metaxalone cocrystals |
| 06/30/2011 | WO2011076811A1 Carboxamide compounds and their use as calpain inhibitors |
| 06/30/2011 | WO2007113540A8 Regulating fat and carbohydrate oxidation in muscle tissue comprising controlling carnitine content in muscle |
| 06/30/2011 | US20110160219 Inhibitors of Phosphodiesterase Type 5A for Treating or Preventing Muscle Disease or the Symptoms Thereof in a Patient |
| 06/30/2011 | US20110160163 INHIBITORS OF p38 |
| 06/30/2011 | US20110160119 Anti-inflammatory compounds and uses thereof |
| 06/30/2011 | US20110158968 Methods of making enhanced, autologous fat grafts |
| 06/30/2011 | US20110158956 Treating cancer |
| 06/30/2011 | US20110158947 Sulfonylurea receptor and means for treating ischaemia |
| 06/30/2011 | CA2783704A1 Carboxamide compounds and their use as calpain inhibitors |
| 06/29/2011 | EP2339002A1 Fibroblast growth factor homologs |
| 06/29/2011 | EP2338900A1 A method of detecting and/or identifying adeno-associated virus (AAV) sequences and isolating novel sequences identified thereby |
| 06/29/2011 | EP2338497A1 Treatment and prevention of heat shock protein-associated diseases and conditions |
| 06/29/2011 | CN102106884A Medicinal composition having immunity-regulating function |
| 06/29/2011 | CN102106839A Alprazolam sustained-release preparation and preparation method thereof |
| 06/28/2011 | US7968716 Caspase inhibitors and uses thereof |
| 06/28/2011 | US7968680 Polynucleotides encoding members of the human B lymphocyte activation antigen B7 family and polypeptides encoded thereby |
| 06/28/2011 | US7968545 Compositions useful as inhibitors of voltage-gated ion channels |
| 06/28/2011 | US7968523 Purified rat apoptosis-specific eucaryotic initiation Factor-5A (eIF-5A) and deoxyhypusine synthase nucleic acids and polypeptides |
| 06/28/2011 | US7968336 Methods of isolation, expansion and differentiation of fetal stem cells from chorionic villus, amniotic fluid, and placenta and therapeutic uses thereof |
| 06/28/2011 | CA2470656C Corticotropin releasing factor 2 receptor agonists |
| 06/28/2011 | CA2445834C Dihydroimidazo[4,5-e]indole and 7h-pyrrolo[3,2-f]quinoxaline derivatives as nicotinic acetylcholine receptor ligands and/or serotonergic ligands |
| 06/28/2011 | CA2413086C Benzothiazole derivatives |
| 06/23/2011 | US20110152766 Implant with coating |